PERFORMANCE STATUS DECREASED side effect
What is PERFORMANCE STATUS DECREASED ?Drugs associated with PERFORMANCE STATUS DECREASED
ADVAIR AVANDAMET AVANDIA BUSULFAN CHANTIX COREG GRANISETRON MIRTAZAPINE MYLOTARG NAVELBINE PALIFERMIN PANITUMUMAB REQUIP REVLIMID SANDOSTATIN SINGULAIR SUTENT TEMODAL WELLBUTRINPERFORMANCE STATUS DECREASED : Mirtazapine Side Effects Report #5678719-4
Consumer or non-health professional from UNITED STATES reported MIRTAZAPINE problem on Mar 24, 2008. Female patient, 63 years of age, weighting 85.00 lb, was diagnosed with anorexia, fatigue and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: performance status decreased, . MIRTAZAPINE dosage: 15 MG 1 DAILY PO. During the same period patient was treated with LITHIUM, CLONAZEPAM, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.
PERFORMANCE STATUS DECREASED : Chantix Side Effects Report #5635574-6
CHANTIX problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 12, 2008. Male patient, weighting 69.00 lb, was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: performance status decreased, somnolence, . CHANTIX dosage: unknown. During the same period patient was treated with CARBAMAZEPINE, LORAZEPAM, ATENOLOL, NEURONTIN, CYMBALTA, HYDROCHLOROTHIAZIDE. Patient recovered.
PERFORMANCE STATUS DECREASED : Panitumumab Side Effects Report #5595056-7
Physician from BELGIUM reported PANITUMUMAB problem on Jan 07, 2008. Male patient was diagnosed with squamous cell carcinoma and was treated with PANITUMUMAB. After drug was administered, patient experienced the following problems/side effects: performance status decreased, renal failure, . PANITUMUMAB dosage: unknown. During the same period patient was treated with LEVOTHYROXINE, TRAZOLAN, MORPHINE, CISPLATIN, FLUOROURACIL. Patient was hospitalized. Patient died on 12/23/2007.
PERFORMANCE STATUS DECREASED : Chantix Side Effects Report #5531175-9
CHANTIX problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 18, 2007. Female patient was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: performance status decreased, . CHANTIX dosage: unknown. Patient recovered.
PERFORMANCE STATUS DECREASED : Sutent Side Effects Report #5454489-X
Consumer or non-health professional from ARGENTINA reported SUTENT problem on Sept 05, 2007. Male patient was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: performance status decreased, . SUTENT dosage: unknown. Patient recovered.
PERFORMANCE STATUS DECREASED : Navelbine Side Effects Report #5472281-7
NAVELBINE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 04, 2007. Female patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: performance status decreased, respiratory failure, . NAVELBINE dosage: 25 MG/M2 IV. Patient died.
PERFORMANCE STATUS DECREASED : Navelbine Side Effects Report #5472282-9
Consumer or non-health professional from UNITED STATES reported NAVELBINE problem on Sept 04, 2007. Female patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: performance status decreased, respiratory failure, . NAVELBINE dosage: 25 MG/M2 IV. Patient died.
PERFORMANCE STATUS DECREASED : Mylotarg Side Effects Report #5652919-1
MYLOTARG problem was reported by a Physician from JAPAN on Feb 26, 2008. Female patient, weighting 112.4 lb, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased, performance status decreased, . MYLOTARG dosage: unknown. During the same period patient was treated with CEFZON, MEROPEN, DIFLUCAN, MAXIPIME. Patient was hospitalized. Patient recovered.
PERFORMANCE STATUS DECREASED : Chantix Side Effects Report #5620863-1
Consumer or non-health professional from UNITED STATES reported CHANTIX problem on Jan 28, 2008. Female patient, weighting 149.9 lb, was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: dizziness, performance status decreased, . CHANTIX dosage: unknown. During the same period patient was treated with VITAMIN B, FISH OIL. Patient recovered.
PERFORMANCE STATUS DECREASED : Panitumumab Side Effects Report #5637189-2
PANITUMUMAB problem was reported by a Physician from BELGIUM on Feb 11, 2008. Male patient was diagnosed with squamous cell carcinoma and was treated with PANITUMUMAB. After drug was administered, patient experienced the following problems/side effects: escherichia infection, performance status decreased, renal failure, . PANITUMUMAB dosage: unknown. During the same period patient was treated with LEVOTHYROXINE, TRAZOLAN, MORPHINE, CISPLATIN, FLUOROURACIL, CORSODYL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE. Patient was hospitalized. Patient died on 12/23/2007.
PERFORMANCE STATUS DECREASED : Mylotarg Side Effects Report #5581454-4
Physician from JAPAN reported MYLOTARG problem on Dec 25, 2007. Female patient, weighting 112.4 lb, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased, performance status decreased, . MYLOTARG dosage: unknown. During the same period patient was treated with CEFZON, MEROPEN, DIFLUCAN, MAXIPIME. Patient recovered.
PERFORMANCE STATUS DECREASED : Sutent Side Effects Report #5514646-0
SUTENT problem was reported by a Consumer or non-health professional from ARGENTINA on Nov 01, 2007. Male patient, weighting 154.3 lb, was diagnosed with renal cancer metastatic and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: anaemia, performance status decreased, . SUTENT dosage: unknown. During the same period patient was treated with AMINO ACIDS, MEGESTROL ACETATE. Patient recovered.
PERFORMANCE STATUS DECREASED : Coreg Side Effects Report #5519902-8
Consumer or non-health professional from UNITED STATES reported COREG CR problem on Oct 12, 2007. Female patient was treated with COREG CR. After drug was administered, patient experienced the following problems/side effects: lethargy, performance status decreased, . COREG CR dosage: unknown. During the same period patient was treated with CELEBREX, FOSAMAX, EVISTA, IMDUR, POLYPHARMACY. Patient recovered.
PERFORMANCE STATUS DECREASED : Avandamet Side Effects Report #5520902-2
AVANDAMET problem was reported by a Consumer or non-health professional from GERMANY on Nov 14, 2007. Male patient, 70 years of age, was treated with AVANDAMET. After drug was administered, patient experienced the following problems/side effects: anaemia, performance status decreased, . AVANDAMET dosage: 1002MG TWICE PER DAY. During the same period patient was treated with METFORMIN HYDROCHLORIDE. Patient recovered.
PERFORMANCE STATUS DECREASED : Sutent Side Effects Report #5525826-2
Consumer or non-health professional from ARGENTINA reported SUTENT problem on Nov 14, 2007. Male patient, weighting 154.3 lb, was diagnosed with renal cancer metastatic and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: anaemia, performance status decreased, . SUTENT dosage: unknown. During the same period patient was treated with AMINO ACIDS, MEGESTROL. Patient recovered.
PERFORMANCE STATUS DECREASED : Mylotarg Side Effects Report #5493374-4
MYLOTARG problem was reported by a Physician from JAPAN on Oct 11, 2007. Female patient, weighting 85.98 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, performance status decreased, platelet count decreased, pleural effusion, sepsis, weight increased, . MYLOTARG dosage: unknown. During the same period patient was treated with BAKTAR, LEVOFLOXACIN, FLAGYL, VANCOMYCIN, ITRIZOLE. Patient died on 06/22/2007.
PERFORMANCE STATUS DECREASED : Sutent Side Effects Report #5502371-1
Consumer or non-health professional from ARGENTINA reported SUTENT problem on Oct 18, 2007. Male patient, weighting 154.3 lb, was diagnosed with renal cancer metastatic and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: anaemia, performance status decreased, . SUTENT dosage: unknown. During the same period patient was treated with AMINO ACIDS, MEGESTROL ACETATE. Patient recovered.
PERFORMANCE STATUS DECREASED : Busulfan Side Effects Report #5447576-3
BUSULFAN problem was reported by a Consumer or non-health professional from JAPAN on Aug 22, 2007. Male patient, child 10 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: multi-organ failure, performance status decreased, venoocclusive liver disease, . BUSULFAN dosage: 0.8 MG/KG;1X;. Patient died on 05/27/2007.
PERFORMANCE STATUS DECREASED : Sutent Side Effects Report #5468783-X
Consumer or non-health professional from ARGENTINA reported SUTENT problem on Sept 17, 2007. Male patient, weighting 154.3 lb, was diagnosed with renal cancer metastatic and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: anaemia, performance status decreased, . SUTENT dosage: unknown. During the same period patient was treated with AMINO ACIDS, MEGESTROL ACETATE. Patient recovered.
PERFORMANCE STATUS DECREASED : Chantix Side Effects Report #5472043-0
CHANTIX problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 18, 2007. Female patient was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: fatigue, performance status decreased, . CHANTIX dosage: unknown. Patient recovered.
PERFORMANCE STATUS DECREASED : Navelbine Side Effects Report #5472283-0
Consumer or non-health professional from UNITED STATES reported NAVELBINE problem on Sept 04, 2007. Female patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: infection, performance status decreased, . NAVELBINE dosage: 25 MG/M2 IV. During the same period patient was treated with DOCETAXEL. Patient died.
PERFORMANCE STATUS DECREASED : Temodal Side Effects Report #5442991-6
TEMODAL problem was reported by a Physician from UNITED KINGDOM on Aug 24, 2007. Female patient, 78 years of age, weighting 165.1 lb, was diagnosed with glioblastoma and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, performance status decreased, pharyngolaryngeal pain, . TEMODAL dosage: 15 MG; QD; PO. During the same period patient was treated with PHENYTOIN, DEXAMETHASONE, DOMPERIDONE. Patient was hospitalized. Patient recovered.
PERFORMANCE STATUS DECREASED : Granisetron Side Effects Report #5394389-7
Physician from AUSTRIA reported GRANISETRON problem on July 13, 2007. Male patient was treated with GRANISETRON. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, performance status decreased, resuscitation, . GRANISETRON dosage: unknown. During the same period patient was treated with METOCLOPRAMIDE, PANTOPRAZOL, ALLOPURINOL, LISINOPRIL, NIFEDIPINE, ATENOLOL, CAPECITABINE, BEVACIZUMAB. Patient was hospitalized. Patient recovered.
PERFORMANCE STATUS DECREASED : Granisetron Side Effects Report #5394389-7
GRANISETRON problem was reported by a Physician from AUSTRIA on July 13, 2007. Male patient was treated with GRANISETRON. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, performance status decreased, resuscitation, . GRANISETRON dosage: unknown. During the same period patient was treated with METOCLOPRAMIDE, PANTOPRAZOL, ALLOPURINOL, LISINOPRIL, NIFEDIPINE, ATENOLOL, CAPECITABINE, BEVACIZUMAB. Patient was hospitalized. Patient recovered.
PERFORMANCE STATUS DECREASED : Requip Side Effects Report #5654788-2
Consumer or non-health professional from UNITED STATES reported REQUIP problem on July 13, 2007. Male patient, 21 years of age, was diagnosed with restless legs syndrome and was treated with REQUIP. After drug was administered, patient experienced the following problems/side effects: disability, feeling abnormal, performance status decreased, . REQUIP dosage: unknown. Patient recovered.
PERFORMANCE STATUS DECREASED : Mylotarg Side Effects Report #5664832-4
MYLOTARG problem was reported by a Physician from JAPAN on Mar 07, 2008. Female patient, weighting 101.4 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: anaemia, neutrophil count decreased, performance status decreased, platelet count decreased, subdural haematoma, . MYLOTARG dosage: unknown. During the same period patient was treated with MEILAX, FAMOTIDINE, BAKTAR, CARBENIN, BIKLIN. Patient died on 06/11/2007.
PERFORMANCE STATUS DECREASED : Chantix Side Effects Report #5669946-0
Consumer or non-health professional from UNITED STATES reported CHANTIX problem on Mar 05, 2008. Male patient, weighting 197.1 lb, was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: motor dysfunction, mutism, performance status decreased, . CHANTIX dosage: unknown. During the same period patient was treated with AMOXICILLIN. Patient recovered.
PERFORMANCE STATUS DECREASED : Chantix Side Effects Report #5676250-3
CHANTIX problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 10, 2008. Male patient, 44 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: attention deficit/hyperactivity disorder, performance status decreased, . CHANTIX dosage: unknown. During the same period patient was treated with STRATTERA, METHYLPHENIDATE, REQUIP. Patient recovered.
PERFORMANCE STATUS DECREASED : Chantix Side Effects Report #5685393-X
Consumer or non-health professional from UNITED STATES reported CHANTIX problem on Mar 18, 2008. Female patient, weighting 149.9 lb, was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: asthenia, muscular weakness, performance status decreased, . CHANTIX dosage: unknown. Patient recovered.
PERFORMANCE STATUS DECREASED : Singulair Side Effects Report #5690680-5
SINGULAIR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 31, 2008. Female patient, 41 years of age, weighting 220.0 lb, was diagnosed with seasonal allergy and was treated with SINGULAIR. After drug was administered, patient experienced the following problems/side effects: depression, impaired work ability, performance status decreased, suicidal ideation, . SINGULAIR dosage: 10 MG DAILY PO. Patient recovered.
PERFORMANCE STATUS DECREASED : Advair Side Effects Report #5622644-1
Consumer or non-health professional from UNITED STATES reported ADVAIR DISKUS problem on Feb 11, 2008. Male patient, 24 years of age, weighting 180.0 lb, was diagnosed with asthma and was treated with ADVAIR DISKUS. After drug was administered, patient experienced the following problems/side effects: depression, feeling abnormal, performance status decreased, vision blurred, . ADVAIR DISKUS dosage: unknown. Patient recovered.
PERFORMANCE STATUS DECREASED : Sandostatin Side Effects Report #5631796-9
SANDOSTATIN LAR problem was reported by a Physician from BELGIUM on Feb 12, 2008. Male patient, 64 years of age, weighting 116.8 lb, was diagnosed with carcinoid tumour and was treated with SANDOSTATIN LAR. After drug was administered, patient experienced the following problems/side effects: diarrhoea, fatigue, performance status decreased, . SANDOSTATIN LAR dosage: unknown. Patient was hospitalized. Patient recovered.
PERFORMANCE STATUS DECREASED : Sandostatin Side Effects Report #5636342-1
Physician from BELGIUM reported SANDOSTATIN LAR problem on Feb 18, 2008. Male patient, 64 years of age, weighting 116.8 lb, was diagnosed with carcinoid tumour and was treated with SANDOSTATIN LAR. After drug was administered, patient experienced the following problems/side effects: diarrhoea, fatigue, performance status decreased, . SANDOSTATIN LAR dosage: unknown. Patient was hospitalized. Patient died on 02/17/2008.
PERFORMANCE STATUS DECREASED : Revlimid Side Effects Report #5613625-2
REVLIMID problem was reported by a Physician from UNITED STATES on Jan 21, 2008. Female patient, 75 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: constipation, fatigue, performance status decreased, weight decreased, . REVLIMID dosage: 15 MG, QD, ORAL; 25 MG, QD, ORAL. Patient died on 08/27/2007.
PERFORMANCE STATUS DECREASED : Mylotarg Side Effects Report #5570727-7
Physician from JAPAN reported MYLOTARG problem on Dec 12, 2007. Female patient, weighting 101.4 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: anaemia, neutrophil count decreased, performance status decreased, platelet count decreased, subdural haematoma, . MYLOTARG dosage: unknown. During the same period patient was treated with MEILAX, GASTER, BAKTAR, CARBENIN, BIKLIN. Patient died on 06/05/2007.
PERFORMANCE STATUS DECREASED : Avandia Side Effects Report #5472859-0
AVANDIA problem was reported by a Physician from UNITED STATES on Sept 24, 2007. Male patient was treated with AVANDIA. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, ejection fraction decreased, performance status decreased, . AVANDIA dosage: unknown. Patient recovered.
PERFORMANCE STATUS DECREASED : Chantix Side Effects Report #5473836-6
Consumer or non-health professional from UNITED STATES reported CHANTIX problem on Sept 19, 2007. Female patient, weighting 145.1 lb, was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: dizziness, nausea, performance status decreased, stomach discomfort, . CHANTIX dosage: unknown. During the same period patient was treated with IBUPROFEN. Patient recovered.
PERFORMANCE STATUS DECREASED : Wellbutrin Side Effects Report #5430826-7
WELLBUTRIN problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 05, 2006. Female patient was diagnosed with depression and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: depression, pain, performance status decreased, therapeutic response unexpected, . WELLBUTRIN dosage: 300MG PER DAY. Patient recovered.
PERFORMANCE STATUS DECREASED : Palifermin Side Effects Report #5380549-8
Physician from GERMANY reported PALIFERMIN problem on June 29, 2007. Male patient was diagnosed with mucosal inflammation and was treated with PALIFERMIN. After drug was administered, patient experienced the following problems/side effects: blood test abnormal, hepatic cirrhosis, performance status decreased, . PALIFERMIN dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.
PERFORMANCE STATUS DECREASED : Palifermin Side Effects Report #5380549-8
PALIFERMIN problem was reported by a Physician from GERMANY on June 29, 2007. Male patient was diagnosed with mucosal inflammation and was treated with PALIFERMIN. After drug was administered, patient experienced the following problems/side effects: blood test abnormal, hepatic cirrhosis, performance status decreased, . PALIFERMIN dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.